Zealand Pharma A/S | ZEAL - Creditori Commerciali

Prezzo Delle Azioni
299.40
Cambio Giornaliero
-1.60 -0.53%
Mensile
1.49%
Annuale
-35.82%
Q2 Previsione
288.68




Creditori Commerciali Cambiamento Data
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alaunos Therapeutics USD 843K 34K 2025-09
Avita Medical AUD 8.96M 1.69M 2025-12
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
IQVIA Holdings USD 3.75B 201M 2025-12
Moderna USD 317M 50M 2025-12
Organon & Co USD 952M 122M 2025-12
Revvity USD 185.46M 9.66M 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
Tilray USD 114.5M 3.69M 2025-09
Viatris USD 1.33B 6.4M 2025-09
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12
Zealand Pharma A/S 346.6M 102.71M 2025-12